{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:42:28Z","timestamp":1789332148009,"version":"build-2803163510"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 56-year-old man who was recently diagnosed with a carcinoid tumor of the os petrosum was referred for a <jats:sup>68<\/jats:sup>Ga-DOTA-TOC PET\/CT scan. Besides the moderately increased <jats:sup>68<\/jats:sup>Ga-DOTA-TOC accumulation in the carcinoid tumor, the scan showed strongly increased and focal <jats:sup>68<\/jats:sup>Ga-DOTA-TOC uptake in an additional lesion in the right parotid gland. The markedly different <jats:sup>68<\/jats:sup>Ga-DOTA-TOC avidity suggested a different etiology, and histological examination demonstrated a pleomorphic adenoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002133","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T01:19:41Z","timestamp":1527729581000},"page":"524-525","source":"Crossref","is-referenced-by-count":8,"title":["68Ga-DOTA-TOC Uptake in Pleomorphic Adenoma"],"prefix":"10.1097","volume":"43","author":[{"given":"S. Tom","family":"Laurens","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana T.","family":"Netea-Maier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.H.G.","family":"Aarntzen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","article-title":"68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0194-5998(99)70323-2","article-title":"Incidence rates of salivary gland tumors: results from a population based-study","volume":"120","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clinimag.2015.03.011","article-title":"Clinical significance of parotid gland incidentalomas on (18)F-FDG PET\/CT","volume":"39","year":"2015","journal-title":"Clin Imaging"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/1097-0142(19841015)54:8<1620::AID-CNCR2820540824>3.0.CO;2-I","article-title":"The prognosis of specific types of salivary gland tumors","volume":"54","year":"1984","journal-title":"Cancer"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000163587","article-title":"Immunopathological study of neuropeptide expression in human salivary gland neoplasms","volume":"58","year":"1990","journal-title":"Pathobiology"},{"key":"bib6-20230925","first-page":"250","article-title":"Immunoreactive somatostatin in Warthin's tumor","volume":"123","year":"1986","journal-title":"Am J Pathol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2967\/jnumed.117.191197","article-title":"68Ga-DOTATOC imaging of neuroendocrine tumors: a systematic review and metaanalysis","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0284185113496679","article-title":"Diagnostic role of gallium-68 DOTATOC and gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis","volume":"55","year":"2014","journal-title":"Acta Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201807000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:05:34Z","timestamp":1695618334000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201807000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002133","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}